Dr. Lang Robertson Liebman, MD

Dr. Liebman practices at Bon Secours St. Mary's Hospital in Richmond, Virginia, part of Bon Secours Mercy Health.

Dr. Liebman's NPI, 1750566014, was assigned on January 7, 2008. Dr. Liebman graduated from VCU School of Medicine in 2006. Dr. Liebman holds Virginia license 0101248710.

Dr. Liebman's primary practice is Bon Secours St. Mary's Hospital, at 5801 Bremo Rd, Richmond, VA 23226 in Richmond City. The practice phone is (804) 285-2011.

Dr. Liebman's primary practice is Bon Secours St. Mary's Hospital in Richmond, Virginia, part of Bon Secours Mercy Health. Dr. Liebman is also affiliated with Chippenham Hospital. The medical group on file is Virginia Urology. Dmand AI also links Dr. Liebman to 2 more hospitals and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Liebman practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Liebman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Liebman is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Liebman's licenses on file in 2 states: Virginia and Georgia.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cervical cancer radiation, lung cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Liebman treats.

CMS data shows 2,008 Medicare services from Dr. Liebman across 22 procedure codes in 2024, for 400 Medicare patients. Medicare paid $289,666 for them.

CMS counts 400 Medicare patients who saw Dr. Liebman in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have cancer, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Liebman's median patient age at 71, with 76% women.

In 2024, Dr. Liebman wrote 62 Medicare Part D claims for 32 patients. 94% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $626 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Liebman for performance year 2024, reported as part of a group. Dr. Liebman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Liebman in 2012. Dr. Liebman's most frequent co-authors are Ian Crocker, MD, Brent R. Hayek, MD and Shravan Kandula, MD.

CMS Open Payments shows 77 general payments to Dr. Liebman from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. INSYS Therapeutics Inc paid the most, $44,256.

Dr. Liebman graduated from VCU School of Medicine in 2006.

Dr. Liebman is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.